These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. In vitro evaluation of SF-2103A, a novel carbapenem antibiotic, as a beta-lactamase inhibitor. Niwa T; Yoshida T; Tamura A; Kazuno Y; Inouye S; Ito T; Kojima M J Antibiot (Tokyo); 1986 Jul; 39(7):943-55. PubMed ID: 3019978 [TBL] [Abstract][Full Text] [Related]
3. C-19393 S2 and H2, new carbapenem antibiotics. IV. Inhibitory activity against beta-lactamases. Okonogi K; Nozaki Y; Imada A; Kuno M J Antibiot (Tokyo); 1981 Feb; 34(2):212-7. PubMed ID: 6975270 [TBL] [Abstract][Full Text] [Related]
4. Combined antibacterial activity of amoxicillin with clavulanic acid against ampicillin-resistant strains. Matsuura M; Nakazawa H; Hashimoto T; Mitsuhashi S Antimicrob Agents Chemother; 1980 Jun; 17(6):908-11. PubMed ID: 6967713 [TBL] [Abstract][Full Text] [Related]
5. Antimicrobial and beta-lactamase inhibitory activities of carpetimycins A and B, new carbapenem antibiotics. Kobayashi F; Saino Y; Koshi T; Hattori Y; Nakayama M; Iwasaki A; Mori T; Mitsuhashi S Antimicrob Agents Chemother; 1982 Apr; 21(4):536-44. PubMed ID: 6979308 [TBL] [Abstract][Full Text] [Related]
6. Synergism of PS-5 with penicillins and cephalosporins in antimicrobial activity against beta-lactam-resistant gram-negative microorganisms. Sakamoto M; Ishikura T; Fukagawa Y J Antibiot (Tokyo); 1984 Nov; 37(11):1414-22. PubMed ID: 6334679 [TBL] [Abstract][Full Text] [Related]
7. In-vitro evaluation of ampicillin/brobactam and comparison with other beta-lactam antibiotics. Melchior NH; Keiding J J Antimicrob Chemother; 1991 Jan; 27(1):29-40. PubMed ID: 1646779 [TBL] [Abstract][Full Text] [Related]
8. Beta-lactamase stability and inhibitory activity of meropenem combined with a potent antibacterial activity. Nouda H; Harabe ET; Sumita Y; Okuda T; Fukasawa M Chemotherapy; 1992; 38(4):218-24. PubMed ID: 1473360 [TBL] [Abstract][Full Text] [Related]
9. Imipenem-Relebactam and Meropenem-Vaborbactam: Two Novel Carbapenem-β-Lactamase Inhibitor Combinations. Zhanel GG; Lawrence CK; Adam H; Schweizer F; Zelenitsky S; Zhanel M; Lagacé-Wiens PRS; Walkty A; Denisuik A; Golden A; Gin AS; Hoban DJ; Lynch JP; Karlowsky JA Drugs; 2018 Jan; 78(1):65-98. PubMed ID: 29230684 [TBL] [Abstract][Full Text] [Related]
10. In-vitro evaluation of the four beta-lactamase inhibitors: BRL42715, clavulanic acid, sulbactam, and tazobactam. Muratani T; Yokota E; Nakane T; Inoue E; Mitsuhashi S J Antimicrob Chemother; 1993 Sep; 32(3):421-9. PubMed ID: 8262864 [TBL] [Abstract][Full Text] [Related]
11. Synthesis and beta-lactamase inhibitory activities of some clavulanic acid analogues. Mak CP; Prasad K; Turnowsky F J Antibiot (Tokyo); 1983 Apr; 36(4):398-406. PubMed ID: 6602120 [TBL] [Abstract][Full Text] [Related]
12. Mechanism of beta-lactamase inhibition: differences between sulbactam and other inhibitors. Sawai T; Yamaguchi A Diagn Microbiol Infect Dis; 1989; 12(4 Suppl):121S-129S. PubMed ID: 2591172 [TBL] [Abstract][Full Text] [Related]
13. Comparative evaluation of a new beta-lactamase inhibitor, YTR 830, combined with different beta-lactam antibiotics against bacteria harboring known beta-lactamases. Gutmann L; Kitzis MD; Yamabe S; Acar JF Antimicrob Agents Chemother; 1986 May; 29(5):955-7. PubMed ID: 3015011 [TBL] [Abstract][Full Text] [Related]
14. Beta-lactamase inhibition by acetylmethylene penicillanic acid compared to that of clavulanate and sulbactam. Chin NX; McElrath MJ; Neu HC Chemotherapy; 1988; 34(4):318-25. PubMed ID: 2850139 [TBL] [Abstract][Full Text] [Related]
15. PS-5, a new beta-lactam antibiotic. III. Synergistic effects and inhibitory activity against a beta-lactamase. Okamura K; Sakamoto M; Fukagawa Y; Ishikura T; Lein J J Antibiot (Tokyo); 1979 Apr; 32(4):280-6. PubMed ID: 381269 [TBL] [Abstract][Full Text] [Related]
16. Antibacterial activities of amoxicillin alone and in combination with clavulanic acid correlated with beta-lactamase production. Hsu LY; Chang SC; Luh KT; Hsieh WC Zhonghua Min Guo Wei Sheng Wu Ji Mian Yi Xue Za Zhi; 1991 Aug; 24(3):272-80. PubMed ID: 1818798 [TBL] [Abstract][Full Text] [Related]
17. Inhibition of beta-lactamases by tazobactam and in-vitro antibacterial activity of tazobactam combined with piperacillin. Higashitani F; Hyodo A; Ishida N; Inoue M; Mitsuhashi S J Antimicrob Chemother; 1990 Apr; 25(4):567-74. PubMed ID: 2161820 [TBL] [Abstract][Full Text] [Related]
18. [Activity of 9 beta-lactam antibiotics combined with clavulanic acid or sulbactam against the strains of broad-spectrum beta-lactamase (CTX-1) producing Enterobacteriaceae isolated at the Henri Mondor Hospital]. Legrand P; Soussy CJ; Orsoni A; Brickley X; Duval J Pathol Biol (Paris); 1988 May; 36(5):425-9. PubMed ID: 3043338 [TBL] [Abstract][Full Text] [Related]
19. [Investigation of the susceptibilities of extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella spp. strains to ertapenem and other carbapenems]. Kuzucu C; Yetkin F; Görgeç S; Ersoy Y Mikrobiyol Bul; 2011 Jan; 45(1):28-35. PubMed ID: 21341156 [TBL] [Abstract][Full Text] [Related]
20. Studies on the OA-6129 group of antibiotics, new carbapenem compounds. II. In vitro evaluation. Sakamoto M; Kojima I; Okabe M; Fukagawa Y; Ishikura T J Antibiot (Tokyo); 1982 Oct; 35(10):1264-70. PubMed ID: 7174514 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]